Drug Trial Radar · NCT00124072
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine
Last checked: Nov 20, 2026Latest source record: Feb 1, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12,064
Actual
Start
Jul 1998
Primary completion
May 2008
Study completion May 2008
Sponsor
- Lead sponsor
- University of OxfordAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Merck Sharp & Dohme LLC
- First posted
- Jul 26, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
SEARCH is a randomised, double-blind, multi-centre United Kingdom (UK) trial of 12,064 patients with myocardial infarction (MI) prior to study entry which aims to demonstrate whether a more intensive cholesterol lowering regimen using 80 mg simvastatin daily produces a larger and worthwhile reduction in cardiovascular events compared with a standard 20 mg daily regimen and whether reducing blood homocysteine levels with a daily dose of folic acid 2 mg + vitamin B12 1 mg compared with matching placebo produces a worthwhile reduction in vascular disease.
Conditions
- Cardiovascular Disease
Interventions
Simvastatin 20 mg dailyDrug
Simvastatin 20 mg tablet once daily
Folic acid 2 mg + vitamin B12 1 mg dailyDietary supplement
Folic acid 2 mg + vitamin B12 1 mg tablet once daily
Simvastatin 80 mg dailyDrug
Simvastatin 80 mg tablet once daily
PlaceboDrug
Placebo vitamin B12/folic acid tablet once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Major Vascular Events (MVE)Time frame: 6.7 years median follow-up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CTSU, Richard Doll Building, University of Oxford
Oxford, Oxon, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.